{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:15:38Z","timestamp":1783401338098,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018573","name":"Istanbul Medeniyet University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018573","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Familial Mediterranean Fever (FMF) is the most common hereditary autoinflammatory disease, and secondary amyloidosis remains its most serious complication. We aimed to investigate amyloidosis awareness, colchicine adherence and related factors among FMF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional single-center study, patients with FMF completed a face-to-face questionnaire assessing amyloidosis awareness using structured questions and colchicine adherence through self-reported medication use. Demographic and clinical data were obtained from medical records. Factors associated with amyloidosis awareness and colchicine adherence were evaluated using univariate and multivariable analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 185 patients were included; 64% were female. The median age was 38\u00a0years and disease duration was 13\u00a0years. Regular colchicine use was reported by 144 (78%) patients and was associated with awareness of its importance, older age, higher colchicine dose, and fewer attacks. Only 51 (27%) patients were completely or partially aware of amyloidosis, whereas 153 (83%) were aware of the risk of renal failure. Amyloidosis awareness was associated with younger age and higher education level. In multivariable analysis, regular colchicine use was independently associated with fewer attacks and a higher daily colchicine dose; while amyloidosis awareness was independently associated with awareness of the amyloidosis risk related to irregular colchicine use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Awareness of amyloidosis remains insufficient among patients with FMF, although colchicine adherence was high. Targeted educational strategies may be needed to improve awareness of amyloidosis and its prevention.<\/jats:p>\n                    <jats:p>\n                      <jats:table-wrap>\n                        <jats:table>\n                          <jats:tbody>\n                            <jats:tr>\n                              <jats:td align=\"left\" colspan=\"2\">\n                                <jats:bold>Key Points<\/jats:bold>\n                                \u2022\n                                <jats:italic>Awareness of amyloidosis was limited (27%) and was associated only with awareness of the amyloidosis risk related to irregular colchicine use<\/jats:italic>\n                                .\u2022\n                                <jats:italic>Treatment adherence is closely linked to higher colchicine dose and fewer attacks<\/jats:italic>\n                                .\n                              <\/jats:td>\n                            <\/jats:tr>\n                          <\/jats:tbody>\n                        <\/jats:table>\n                      <\/jats:table-wrap>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10067-026-08221-9","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T05:24:54Z","timestamp":1781241894000},"page":"4467-4473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amyloidosis awareness and colchicine adherence in patients with familial Mediterranean fever: a cross-sectional study in an endemic region"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-9927","authenticated-orcid":false,"given":"Elif","family":"Dincses-Nas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevilay","family":"Batibay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ender","family":"Igneci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seda Gunay","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esen","family":"Kasapoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"6","key":"8221_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00296-005-0074-3","volume":"26","author":"F Onen","year":"2006","unstructured":"Onen F (2006) Familial Mediterranean fever. Rheumatol Int 26(6):489\u2013496. https:\/\/doi.org\/10.1007\/s00296-005-0074-3","journal-title":"Rheumatol Int"},{"issue":"1 Pt 2","key":"8221_CR2","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.lpm.2018.08.014","volume":"48","author":"H Ozdogan","year":"2019","unstructured":"Ozdogan H, Ugurlu S (2019) Familial Mediterranean Fever. Presse Med 48(1 Pt 2):e61\u2013e76. https:\/\/doi.org\/10.1016\/j.lpm.2018.08.014","journal-title":"Presse Med"},{"issue":"10","key":"8221_CR3","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.55563\/clinexprheumatol\/pzbg88","volume":"43","author":"H Sati\u015f","year":"2025","unstructured":"Sati\u015f H, G\u00fcl A, Ayan G, Babao\u011flu H, Arma\u011fan B, Erden A et al (2025) Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study. Clin Exp Rheumatol 43(10):1709\u20131714. https:\/\/doi.org\/10.55563\/clinexprheumatol\/pzbg88","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"8221_CR4","first-page":"2445","volume":"25","author":"S Ozen","year":"1998","unstructured":"Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E et al (1998) Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study. J Rheumatol 25(12):2445\u20132449","journal-title":"J Rheumatol"},{"issue":"11","key":"8221_CR5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00296-009-0849-z","volume":"29","author":"B Kisacik","year":"2009","unstructured":"Kisacik B, Yildirim B, Tasliyurt T, Ozyurt H, Ozyurt B, Yuce S et al (2009) Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study. Rheumatol Int 29(11):1307\u20131309. https:\/\/doi.org\/10.1007\/s00296-009-0849-z","journal-title":"Rheumatol Int"},{"issue":"1","key":"8221_CR6","doi-asserted-by":"publisher","first-page":"P126","DOI":"10.1186\/1546-0096-13-S1-P126","volume":"13","author":"H Ozdogan","year":"2015","unstructured":"Ozdogan H, Ugurlu S, Hatemi G, Ozgun E, Can G, Ozgon G et al (2015) Is Familial Mediterranean Fever a clinical diagnosis? Results of a field survey. Pediatr Rheumatol 13(1):P126. https:\/\/doi.org\/10.1186\/1546-0096-13-S1-P126","journal-title":"Pediatr Rheumatol"},{"issue":"2","key":"8221_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/rheumatology\/kead465","volume":"63","author":"M Bektas","year":"2023","unstructured":"Bektas M, Koca N, Oguz E, Sari S, Dagci G, Ince B et al (2023) Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey. Rheumatology 63(2):319\u2013328. https:\/\/doi.org\/10.1093\/rheumatology\/kead465","journal-title":"Rheumatology"},{"key":"8221_CR8","doi-asserted-by":"publisher","unstructured":"Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84(1):1\u201311. https:\/\/doi.org\/10.1097\/01.md.0000152370.84628.0c","DOI":"10.1097\/01.md.0000152370.84628.0c"},{"issue":"3","key":"8221_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MD.0b013e3182561a45","volume":"91","author":"S Akar","year":"2012","unstructured":"Akar S, Yuksel F, Tunca M, Soysal O, Solmaz D, Gerdan V et al (2012) Familial Mediterranean fever: risk factors, causes of death, and prognosis in the colchicine era. Medicine (Baltimore) 91(3):131\u2013136. https:\/\/doi.org\/10.1097\/MD.0b013e3182561a45","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"8221_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/rheumatology\/ket400","volume":"53","author":"T Kasifoglu","year":"2014","unstructured":"Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H et al (2014) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology (Oxford) 53(4):741\u2013745. https:\/\/doi.org\/10.1093\/rheumatology\/ket400","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"8221_CR11","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s00296-024-05706-1","volume":"44","author":"R Bourguiba","year":"2024","unstructured":"Bourguiba R, Deshayes S, Amaryan G, Kone-Paut I, Belot A, Sarkisyan T et al (2024) Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study. Rheumatol Int 44(12):3107\u20133111. https:\/\/doi.org\/10.1007\/s00296-024-05706-1","journal-title":"Rheumatol Int"},{"issue":"8","key":"8221_CR12","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1093\/rheumatology\/keaf181","volume":"64","author":"A Vitale","year":"2025","unstructured":"Vitale A, Caggiano V, Sbalchiero J, Tufan A, Batu ED, Ragab G et al (2025) Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry. Rheumatology (Oxford) 64(8):4776\u20134787. https:\/\/doi.org\/10.1093\/rheumatology\/keaf181","journal-title":"Rheumatology (Oxford)"},{"key":"8221_CR13","first-page":"44","volume":"5","author":"E Ozkan","year":"1972","unstructured":"Ozkan E, Okur O, Ekmekci A, Ozcan R, Tag T (1972) A new approach to the treatment of periodic fever 5:44\u201349","journal-title":"A new approach to the treatment of periodic fever"},{"issue":"25","key":"8221_CR14","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/nejm197212212872514","volume":"287","author":"SE Goldfinger","year":"1972","unstructured":"Goldfinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287(25):1302. https:\/\/doi.org\/10.1056\/nejm197212212872514","journal-title":"N Engl J Med"},{"issue":"16","key":"8221_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D Zemer","year":"1986","unstructured":"Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314(16):1001\u20131005. https:\/\/doi.org\/10.1056\/NEJM198604173141601","journal-title":"N Engl J Med"},{"key":"8221_CR16","doi-asserted-by":"publisher","unstructured":"Livneh A, Zemer D, Langevitz P, Laor A, Sohar E, Pras M (1994) Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome. Arthritis Rheum 37(12):1804\u201311. https:\/\/doi.org\/10.1002\/art.1780371215","DOI":"10.1002\/art.1780371215"},{"issue":"2","key":"8221_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","volume":"43","author":"E Sohar","year":"1967","unstructured":"Sohar E, Gafni J, Pras M, Heller H (1967) Familial Mediterranean fever. Am J Med 43(2):227\u2013253. https:\/\/doi.org\/10.1016\/0002-9343(67)90167-2","journal-title":"Am J Med"},{"issue":"48","key":"8221_CR18","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.3346\/jkms.2023.38.e403","volume":"38","author":"O Zimba","year":"2023","unstructured":"Zimba O, Gasparyan AY (2023) Designing, Conducting, and Reporting Survey Studies: A Primer for Researchers. J Korean Med Sci 38(48):e403. https:\/\/doi.org\/10.3346\/jkms.2023.38.e403","journal-title":"J Korean Med Sci"},{"issue":"10","key":"8221_CR19","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/s0735-1097(02)02529-9","volume":"40","author":"CN Merz","year":"2002","unstructured":"Merz CN, Buse JB, Tuncer D, Twillman GB (2002) Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes. J Am Coll Cardiol 40(10):1877\u20131881. https:\/\/doi.org\/10.1016\/s0735-1097(02)02529-9","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"8221_CR20","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-025-07872-4","volume":"45","author":"I Bashan","year":"2026","unstructured":"Bashan I, Ozturk GY, Selvi H, Kocyigit BF, Okyar B (2026) Development of the treatment adherence scale for rheumatic diseases. Clin Rheumatol 45(3):2055\u20132065. https:\/\/doi.org\/10.1007\/s10067-025-07872-4","journal-title":"Clin Rheumatol"},{"issue":"10","key":"8221_CR21","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.55563\/clinexprheumatol\/qdl1yj","volume":"43","author":"A G\u00fcl","year":"2025","unstructured":"G\u00fcl A, Ben-Chetrit E (2025) The decline of AA amyloidosis in familial Mediterranean fever is significant, but the story is not over. Clin Exp Rheumatol 43(10):1715\u20131717. https:\/\/doi.org\/10.55563\/clinexprheumatol\/qdl1yj","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"8221_CR22","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.3906\/sag-2102-328","volume":"51","author":"E Tekgoz","year":"2021","unstructured":"Tekgoz E, Colak S, Cinar FI, Yilmaz S, Cinar M (2021) Non-adherence to colchicine treatment is a common misevaluation in familial Mediterranean fever 51(5):2357\u20132363. https:\/\/doi.org\/10.3906\/sag-2102-328","journal-title":"Non-adherence to colchicine treatment is a common misevaluation in familial Mediterranean fever"},{"issue":"2 Suppl 53","key":"8221_CR23","first-page":"S1","volume":"27","author":"E Ben-Chetrit","year":"2009","unstructured":"Ben-Chetrit E, Aamar S (2009) About colchicine compliance, resistance and virulence. Clin Exp Rheumatol 27(2 Suppl 53):S1-3","journal-title":"Clin Exp Rheumatol"},{"issue":"6 Suppl 94","key":"8221_CR24","first-page":"S156","volume":"33","author":"S Yesilkaya","year":"2015","unstructured":"Yesilkaya S, Acikel C, Fidanci BE, Polat A, Sozeri B, Ayaz NA et al (2015) Development of a medication adherence scale for familial Mediterranean fever (MASIF) in a cohort of Turkish children. Clin Exp Rheumatol 33(6 Suppl 94):S156\u2013S162","journal-title":"Clin Exp Rheumatol"},{"key":"8221_CR25","doi-asserted-by":"publisher","unstructured":"Yilmaz-Oner S, Sen N, Acer Kasman S, Sahin D, Uzun NN, Osken S, et al. (2026) Illness perception as a determinant of medication adherence in adult Turkish patients with familial Mediterranean fever. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/z97by2","DOI":"10.55563\/clinexprheumatol\/z97by2"},{"issue":"Suppl 1","key":"8221_CR26","doi-asserted-by":"publisher","first-page":"P81","DOI":"10.1186\/1546-0096-13-S1-P81","volume":"13","author":"Y Karaaslan","year":"2015","unstructured":"Karaaslan Y, Dogan I, Omma A, Sandikci SC (2015) Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle\/Black Sea Region of Turkey (in \u00c7orum region). Pediatr Rheumatol Online J 13(Suppl 1):P81. https:\/\/doi.org\/10.1186\/1546-0096-13-S1-P81","journal-title":"Pediatr Rheumatol Online J"},{"key":"8221_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.70852\/tmj.1766066","volume":"10","author":"\u00d6 Karaka\u015f","year":"2025","unstructured":"Karaka\u015f \u00d6, Sevil SM, Celik Tam D (2025) Treatment adherence in familial Mediterranean fever patients: real-life data from Central Anatolia. Turk Tip Derg 10:108\u2013114. https:\/\/doi.org\/10.70852\/tmj.1766066","journal-title":"Turk Tip Derg"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08221-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08221-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08221-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:28:16Z","timestamp":1783398496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08221-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8221"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08221-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical standards outlined in the 1964 Declaration of Helsinki and its later amendments. Ethical approval was obtained from the Istanbul Medeniyet University Ethics Committee (2025\/05\u201308).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\u00a0declarations"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}